Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics

IF 3.6 4区 医学 Q2 CHEMISTRY, MEDICINAL
ChemMedChem Pub Date : 2024-09-12 DOI:10.1002/cmdc.202400410
Tiantian Jiang, Yiduo Zhan, Jiayao Ding, Zheming Song, Yijing Zhang, Jingchao Li, Ting Su
{"title":"Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics","authors":"Tiantian Jiang, Yiduo Zhan, Jiayao Ding, Zheming Song, Yijing Zhang, Jingchao Li, Ting Su","doi":"10.1002/cmdc.202400410","DOIUrl":null,"url":null,"abstract":"Nanoparticles can enhance drugs accumulating at the tumor site and hold tremendous promise for achieving effective tumor treatment. However, due to the complexity of cancer heterogeneity and suppressive tumor microenvironment, the delivery of traditional nanoparticles has poor infiltration and off‐target effects, making it difficult to control the drug release rate and causing off‐target toxicity. In recent years, cell membrane‐coated biomimetic nanoparticles have been developed, which have both the natural characteristics of biomembranes and the physical characteristics of traditional nanoparticles, thus improving the homologous targeting ability of nanoparticles to tumor cells and better biocompatibility. In this paper, we reviewed the application of single cell membrane and hybrid cell membrane‐coated biomimetic nanoparticles in the integration for tumor diagnosis and treatment. We talked about the preparation methods of cell membrane‐coated nanoparticles, the targeting mechanisms, and the effects of imaging and therapeutic outcomes of different cell membrane‐coated biomimetic nanoparticles in detail. Finally, we discussed the existing problems and prospects of cell membrane‐coated biomimetic nanomaterials.","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cmdc.202400410","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Nanoparticles can enhance drugs accumulating at the tumor site and hold tremendous promise for achieving effective tumor treatment. However, due to the complexity of cancer heterogeneity and suppressive tumor microenvironment, the delivery of traditional nanoparticles has poor infiltration and off‐target effects, making it difficult to control the drug release rate and causing off‐target toxicity. In recent years, cell membrane‐coated biomimetic nanoparticles have been developed, which have both the natural characteristics of biomembranes and the physical characteristics of traditional nanoparticles, thus improving the homologous targeting ability of nanoparticles to tumor cells and better biocompatibility. In this paper, we reviewed the application of single cell membrane and hybrid cell membrane‐coated biomimetic nanoparticles in the integration for tumor diagnosis and treatment. We talked about the preparation methods of cell membrane‐coated nanoparticles, the targeting mechanisms, and the effects of imaging and therapeutic outcomes of different cell membrane‐coated biomimetic nanoparticles in detail. Finally, we discussed the existing problems and prospects of cell membrane‐coated biomimetic nanomaterials.
用于癌症血清学的仿生细胞膜包覆纳米粒子
纳米颗粒能增强药物在肿瘤部位的蓄积,为实现有效的肿瘤治疗带来巨大希望。然而,由于肿瘤异质性和抑制性肿瘤微环境的复杂性,传统纳米颗粒的给药具有浸润性差、脱靶效应强等特点,导致药物释放速率难以控制,造成脱靶毒性。近年来,细胞膜包覆的仿生物纳米颗粒应运而生,它既具有生物膜的天然特性,又具有传统纳米颗粒的物理特性,从而提高了纳米颗粒对肿瘤细胞的同源靶向能力和更好的生物相容性。本文综述了单细胞膜和混合细胞膜包被生物仿生纳米粒子在肿瘤诊断和治疗一体化中的应用。我们详细介绍了细胞膜包覆纳米粒子的制备方法、靶向机制以及不同细胞膜包覆生物仿生纳米粒子的成像效果和治疗效果。最后,我们讨论了细胞膜包覆仿生纳米材料目前存在的问题和发展前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ChemMedChem
ChemMedChem 医学-药学
CiteScore
6.70
自引率
2.90%
发文量
280
审稿时长
1 months
期刊介绍: Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信